Electrocardiographic and Cardiac Magnetic Resonance Predictors of Ventricular Arrhythmias in Cardiomyopathic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

79 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2023-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess ECG changes for predicting ventricular arrhythmia in cardiomyopathic patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI

NCT04548804

Ventricular Tachycardia Ventricular Arrythmia Ventricular Fibrillation +9 more

ENROLLING_BY_INVITATION NA

China Structural Ventricular Arrhythmias Registry

NCT03821051

Ventricular Arrythmia

RECRUITING

Study on Mechanical and Electrical Alternans

NCT01281241

Heart Failure Ischemia Ventricular Arrhythmia

UNKNOWN

Noninvasive Electrocardiographic Imaging for Individuals at Risk for Apparently Idiopathic Ventricular Fibrillation.

NCT03963271

Ventricular Fibrillation Ventricular Arrythmia Polymorphic Ventricular Tachycardia +7 more

UNKNOWN

Left Ventricular Lead Position in Cardiac Resynchronization Therapy

NCT00748735

Heart Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to assess ECG markers based on 24-hour Holter ECG recordings for predicting ventricular arrhythmia in patients with Structural Heart disease who have left ventricular dysfunction and Left Ventricular Ejection Fraction ≤40%. With special concerns to underlying structural abnormalities in cardiomyopathic patients using Cardiac Magnetic Resonance to determine ventricular function, scar distribution, and grey zone analysis

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Ventricular Complex

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Holter monitoring

24 hours Holter monitoring

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with ischemic and non-ischemic cardiomyopathy, EF \< 40 %
* Patient haemodynamically stable
* Patients accept to make test

Exclusion Criteria

1. Patients with underlying arrhythmia ex heart block or atrial arrhythmia like PACs, AF.
2. Patients on arrhythmogenic drugs ex digitalis, amiodarone.
3. Patients on underlying Pacemaker device or CRT-D.
4. Patients with MI in less than 40 days
5. Patients refuse to make test .

Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No